The Modern Diagnostic & Research Centre Ltd IPO is creating buzz in the market as one of the key SME IPOs closing out the year! If you’re planning to invest or simply want the latest update, here’s everything you need to know — clearly explained and enhanced with emojis for better engagement 😊.
🗓️ IPO Timeline
📅 IPO Open Date: 31 December 2025
📅 IPO Close Date: 2 January 2026
📅 Basis of Allotment: 5–6 January 2026
📅 Expected Listing Date: 7 January 2026
📍 Exchange: BSE SME
This is one of the final IPOs of 2025, attracting strong attention due to the year-end lull in new issues 📊.
💰 IPO Price Band & Issue Size
💸 Price Band: ₹85 – ₹90 per share
📊 Total Issue Size: Approx ₹36.89 Crore (Fresh Issue Only)
📦 Face Value: ₹10 per share
📈 Total Shares Offered: 40,99,200 equity shares
This IPO follows the Book Building route, with bids accepted within the price band.
📦 Lot Size & Investment Details
🔹 Lot Size: 1,600 equity shares
🔹 Minimum Retail Investment: ₹144,000
🔹 Maximum Retail Investment: ₹288,000 (2 lots)
Suitable for investors comfortable with higher-ticket SME IPO investments.
👥 Category-wise Allocation
✔️ Anchor / QIB: Up to 11,61,600 shares
✔️ QIB (Non-anchor): Up to 7,82,400 shares
✔️ NII / HNI: Minimum 5,85,600 shares
✔️ Retail Investors: Minimum 13,63,200 shares
✔️ Market Maker Portion: 2,06,400 shares
🧪 About Modern Diagnostic & Research Centre Ltd (MDRC)
Modern Diagnostic & Research Centre Ltd is a well-established diagnostic services provider, offering a wide spectrum of medical tests and imaging services. Its offerings include:
✔ Advanced Pathology Tests
✔ Radiology & Imaging (CT, MRI, Ultrasound, X-ray)
✔ Wellness Packages
✔ Home Sample Collection
✔ Corporate & Hospital Diagnostic Partnerships
✔ Digital Reports & Patient Support
The company operates 21 diagnostic facilities, including 17 labs and 4 collection/centres, across multiple states — positioning itself strongly in India’s expanding diagnostic healthcare ecosystem.
🌟 Why Investors Are Watching This IPO
✨ Healthcare Sector Growth: Demand for diagnostics continues to rise post-COVID, boosting opportunities for expansion.
✨ Infrastructure Expansion: Funds will be used to purchase advanced medical equipment & strengthen their lab network.
✨ Working Capital Support: Improving financial flexibility for growth.
✨ Year-end SME Highlight: Fewer IPOs at this time means more focus & participation.
🔍 Key Points for Investors
👉 SME IPOs carry higher risk, but may also offer higher growth potential.
👉 Minimum investment is significantly higher than regular mainboard IPOs.
👉 Study subscription numbers, financial performance & GMP trends before applying.
👉 Ensure alignment with your financial goals and risk appetite.
💡 Final Thoughts
The Modern Diagnostic & Research Centre Ltd IPO stands out as a notable SME offering closing out 2025. With strong presence in diagnostics, expansion plans, and market interest, it may appeal to investors looking for opportunities in the healthcare sector 🔬📊.
However, as always, due diligence and risk assessment are essential before subscribing to any IPO.
⚠️ Disclaimer
The investments & trading ideas recommended in the market analysis, research reports, etc. may not be suitable for all investors. This article or data points do not constitute investment advice, as stock market investments are subject to market risks. Please consult your financial advisor before making any investment or trading decisions.
All information provided is a point of view and is strictly for educational, learning, and informational purposes only. The author or group admin accepts no liability for any interpretation of the articles or comments on this platform being used for actual investments.
Registration granted by SEBI and certification from NISM in no way guarantee performance of any intermediary or provide assurance of returns. Investors must make their own decisions based on their specific financial goals, risk appetite and personal financial situation after consulting with a registered market professional.